News

Core & Main Reports Impressive Growth in Q3 Fiscal 2024

Core & Main Reports Impressive Growth in Q3 Fiscal 2024

Core & Main Achieves Record Fiscal 2024 Third Quarter Results

Core & Main Inc. (NYSE: CNM), a premier specialty distributor dedicated to enhancing reliable infrastructure across the nation, has reported impressive financial outcomes for the third quarter of the fiscal year 2024. Despite a challenging economic landscape, the company demonstrated resilience and strategic foresight that propelled its performance, showcasing their commitment to investing in innovation.

Significant Financial Highlights for Q3

The third quarter was marked by several key financial metrics that emphasize the strength of Core & Main's operations. Net sales surged by an astounding 11.5% to reach $2,038 million, compared to $1,827 million during the same period last year. This growth was primarily driven by strategic acquisitions that broadened the company's product offerings and enhanced market penetration.

Key Performance Metrics

  • Gross profit grew by 9.9% to $543 million, with an increase in gross profit margin to 26.6%.
  • Net income saw a slight decline of 11.4%, totaling $140 million.
  • Diluted earnings per share increased by 6.2%, reaching $0.69.
  • Adjusted EBITDA rose 6.5% to $277 million, maintaining an Adjusted EBITDA margin at 13.6%.
  • During the quarter, the company completed five strategic acquisitions, significantly boosting their operational capabilities and market shares.

Leadership Comments on Growth Strategy

Steve LeClair, the Chair and CEO of Core & Main, stated, "Our stellar performance in the third quarter underscores our ability to thrive in any market condition. By focusing on organic growth and a disciplined approach to mergers and acquisitions, we have achieved nearly 12% sales growth. Our commitment to driving organic market share gains, coupled with strategic capital allocation, demonstrates our dedication to creating shareholder value."

Market Trends and Customer Demand

Core & Main remains focused on enhancing its presence in the infrastructure supply chain. This initiative is reinforced by the introduction of advanced technology, such as smart meter adoption in municipalities, which has been a crucial driving force behind the increased demand for their products. Moreover, the management's strategy to expand into key geographic markets helps in catering to a diverse customer base.

Operational Insights

Throughout the quarter, Core & Main experienced robust demand across various product categories, particularly in pipes, valves, and fittings. The company capitalized on market trends, increasing sales volume while maintaining competitive pricing on widely used storm drainage systems. However, sales in the fire protection product segment experienced a dip due to lower selling prices and reduced market demand.

Financial Outlook for the Remainder of 2024

Looking ahead, Core & Main has raised its full-year outlook based on its performance thus far, as well as the positive impacts of recent acquisitions. The company expects net sales to range from $7,350 million to $7,450 million, with Adjusted EBITDA projected between $915 million and $935 million. LeClair conveyed optimism regarding the company's potential to deliver substantial long-term value through its scale and innovative culture.

Company Overview

Core & Main is at the forefront of advancing reliable infrastructure, offering a range of products and services tailored to meet the demands of municipalities, private water companies, and professionals in construction across residential, non-residential, and municipal markets. With over 350 locations nationwide and nearly 5,500 employees, the company strives to empower communities with safe and sustainable utility solutions.

Frequently Asked Questions

What is Core & Main's primary focus?

Core & Main primarily focuses on providing reliable infrastructure solutions, particularly in the water, wastewater, and fire protection sectors.

How did Core & Main perform financially in Q3 2024?

The company reported a net sales increase of 11.5% to $2,038 million, with gross profit rising by 9.9% to $543 million.

What strategic moves did Core & Main make recently?

Core & Main successfully completed five acquisitions during and after the quarter, enhancing their product offerings and market presence.

What is the company's outlook for the rest of 2024?

Core & Main has raised its expectations for the year, forecasting net sales between $7,350 million and $7,450 million.

How does Core & Main support its customers?

By leveraging its extensive supply chain and local expertise, Core & Main works to ensure efficient product delivery and meet complex customer needs.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

OMLYCLO Shakes Up U.S. Biologic Market as Key Player

Updated Category News Views 11

Ah, the pharmaceutical game is shifting again, and this time Celltrion USA's putting their chips down with OMLYCLO, the shiny new omalizumab biosimilar. Here we see a product that's not just approved but interchangeable with XOLAIR, making it a front-runner in the allergic and inflammatory conditions battleground. If you're a patient or a provider navigating these murky...

Continue Reading
China Automotive Systems Hits Milestone with ASPICE 4.0 CL2

Updated Category News Views 8

An Automotive Feat in R&D Now here's a story that should make waves across the automotive sector. China Automotive Systems, Inc. (NASDAQ: CAAS), a titan of power steering development in China, has nailed it by meeting the ASPICE 4.0 Capability Level 2. That's a big one, folks. Verified by a partnership between a European automaker and UL, this achievement is no fluke....

Continue Reading
Aging at Home: The Real Costs and Obstacles Ahead

Updated Category News Views 6

Facing the Realities of Aging In Place Alright, let's talk straight. Everyone dreams of staying home in their twilight years, kicking back in their favorite chair with family nearby. But the harsh truth? That comfort comes with a price tag. According to Northwestern Mutual's 2026 Planning & Progress Study, up to 83% of Boomers+ and most other generations fancy the idea of...

Continue Reading
Hilarity and Hassles in NYC Co-op Life Exposed in New Book

Updated Category News Views 10

Co-op Living: Not All It's Cracked Up to Be Let me tell you something, buying a co-op in New York City isn't just signing on the dotted line and moving in. Nope, it's a whole damn production. Jeff Namian's book, Thin Walls/Thick Ears, lays it all out with a mix of humor and hard truths, painting a stark picture of NYC co-op living. He's not just telling his own story of...

Continue Reading
Dan Brown Joins Guidewire: Big Moves in P&C Software

Updated Category News Views 7

Turning the Insurance World on Its Head Just when you think the enterprise software scene is getting predictable, along comes a bit of news to shake things up. Guidewire, a name known in the P&C insurance software world, has roped in a veteran—Dan Brown—who's got more than a quarter-century under his belt shaping product strategies. It’s not just another suit...

Continue Reading
TRIMAX Poised to Meet AI-Driven Power Challenges

Updated Category News Views 8

TRIMAX's Bold Move into AI-Powered Infrastructure It feels like we're standing on the cusp of a seismic shift, folks. Artificial intelligence isn't just another buzzword anymore—it's a juggernaut reshaping our digital world. TRIMAX Power Systems is gearing up to ride this wave, with its eyes set on capturing a chunk of the booming demand for fast-deployable power...

Continue Reading
Palm Beach Royals Boost Pickleball's Popularity Surge

Updated Category News Views 14

A New Era for Pickleball in Palm Beach It might be time to re-evaluate pickleball if you weren't paying attention before. The Palm Beach Royals have wrapped up their first Major League Pickleball season with a bang, marking a pivotal year for the sport. This underdog tale of graft and grit is carving out a new chapter in the world of sport. Record-Breaking Season for MLP...

Continue Reading
Event Industry Power 50 Voting Surge Ahead of Close

Updated Category News Views 8

An Unexpected Wave of Enthusiasm in Event Industry The Event Industry Power 50 is getting some serious action this year. Over 3,500 votes have already rolled in, smashing last year's numbers with days still left on the clock. It seems like folks can't wait to see their favorite event powerhouses crowned at this year's gala, which kicks off October 27 in New York City....

Continue Reading
Hiromi Asai's Akatsuki Shines at Paris Fashion Week

Updated Category News Views 5

An Ode to Tradition Amid Modern Menswear From the bustling avenues of New York to the storied streets of Paris, Hiromi Asai is showcasing something that strikes a chord deep in the fashion industry's soul. Her Spring/Summer 2027 collection, "Akatsuki — Before the Dawn," takes its rare blend of age-old Japanese textile craftsmanship across the pond to the City of Light....

Continue Reading
#L.A. Rising Podcast: From Fires to International Fame

Updated Category News Views 9

From Ashes to Airwaves Gritty stories of survival often cut deeper than any wonky industry analysis or corporate earnings report. When you've been through the wringer and come out the other side, that experience sticks with you—and for Kim S. Marshall, it ignited something personal yet universal with the #L.A. Rising podcast. Emerging from the 2025 L.A. fires, this...

Continue Reading

Top 5 Most Recently Viewed Articles

Giant Tortoises Return to Floreana: A Conservation Milestone

Updated Category News Views 266

Flashback to Floreana: Tortoises Are Back! Let’s get right to it—February 20, 2026, marks a huge day. Those big ol’ giant tortoises, which went missing from Floreana Island for over a century, just made their comeback. Yeah, we're talking about 158 of them, released back into their natural habitat, thanks to the Floreana Ecological Restoration Project. What a sight,...

Continue Reading
Understanding Your Rights as a Five Below, Inc. Shareholder

Updated Category News Views 90

Your Rights as a Shareholder of Five Below, Inc. If you've invested in Five Below, Inc. (NASDAQ: FIVE), protecting your financial interests is crucial. Staying informed about the company's updates that could impact your investments is key. You may face important decisions based on misleading information released by the company. Important Alert for Five Below Shareholders...

Continue Reading
New Findings Revolutionize CTE Detection Through Imaging

Updated Category News Views 74

New Insights into CTE Diagnosis through Neuroimaging COSTA MESA, Calif. — A landmark development in the field of neuroradiology has emerged as the latest authoritative text, Diagnostic Imaging: Brain, Fifth Edition (Elsevier), confirms the ability of functional neuroimaging tools to detect Chronic Traumatic Encephalopathy (CTE) while patients are still living. This...

Continue Reading
DAVIDsTEA Gears Up for Third Quarter Fiscal 2025 Results

Updated Category News Views 135

DAVIDsTEA Prepares for Fiscal 2025 Third Quarter Earnings Call MONTREAL — DAVIDsTEA Inc. (TSX-Venture: DTEA), a premier tea merchant known for its quality offerings, shares that its financial performance for the third quarter of Fiscal 2025 is scheduled to be unveiled before the market opens. This announcement will take place shortly before the webcast on December 16....

Continue Reading
Lexicon's Promising Phase 2b Results on Diabetic Pain Management

Updated Category News Views 415

Lexicon Pharmaceuticals Announces Topline Results from PROGRESS Study Lexicon Pharmaceuticals, Inc. today revealed exciting updates regarding their latest clinical trial, the Phase 2b PROGRESS study. This study scrutinizes the effects of pilavapadin (LX9211), an innovative oral medication designed to alleviate diabetic peripheral neuropathic pain (DPNP), a condition...

Continue Reading